ASX - By Stock
|
MSB |
Re:
Mesoblast stock(rock)-take March 2024
|
|
RnessGness
|
215 |
86K |
5 |
17/04/24 |
17/04/24 |
ASX - By Stock
|
215
|
86K
|
5
|
|
ASX - By Stock
|
MSB |
Re:
Undervalued Fair value $0.85
|
|
RnessGness
|
25 |
8.4K |
24 |
01/04/24 |
01/04/24 |
ASX - By Stock
|
25
|
8.4K
|
24
|
|
ASX - By Stock
|
MSB |
Re:
Undervalued Fair value $0.85
|
|
RnessGness
|
25 |
8.4K |
6 |
01/04/24 |
01/04/24 |
ASX - By Stock
|
25
|
8.4K
|
6
|
|
ASX - By Stock
|
MSB |
Re:
What happens if there is attempt to take over?
|
|
RnessGness
|
16 |
5.7K |
5 |
12/03/24 |
12/03/24 |
ASX - By Stock
|
16
|
5.7K
|
5
|
|
ASX - By Stock
|
MSB |
Re:
2024 Here we go again.
|
|
RnessGness
|
536 |
197K |
9 |
08/03/24 |
08/03/24 |
ASX - By Stock
|
536
|
197K
|
9
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast Partners with BMT CTN on Adult SR-aGVHD Trial
|
|
RnessGness
|
362 |
116K |
7 |
26/02/24 |
26/02/24 |
ASX - By Stock
|
362
|
116K
|
7
|
|
ASX - By Stock
|
MSB |
Re:
banter and General Discussion
|
|
RnessGness
|
9.4K |
2.7M |
1 |
01/02/24 |
01/02/24 |
ASX - By Stock
|
9.4K
|
2.7M
|
1
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Ulcerative Colitis & Crohns Results Presented at ECCO
|
|
RnessGness
|
202 |
84K |
4 |
29/01/24 |
29/01/24 |
ASX - By Stock
|
202
|
84K
|
4
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Ulcerative Colitis & Crohns Results Presented at ECCO
|
|
RnessGness
|
202 |
84K |
6 |
28/01/24 |
28/01/24 |
ASX - By Stock
|
202
|
84K
|
6
|
|
ASX - By Stock
|
MSB |
Re:
Share price today
|
|
RnessGness
|
94 |
22K |
8 |
01/12/23 |
01/12/23 |
ASX - By Stock
|
94
|
22K
|
8
|
|
ASX - By Stock
|
MSB |
Re:
Share price today
|
|
RnessGness
|
94 |
22K |
2 |
30/11/23 |
30/11/23 |
ASX - By Stock
|
94
|
22K
|
2
|
|
ASX - By Stock
|
MSB |
Re:
Share price today
|
|
RnessGness
|
94 |
22K |
1 |
30/11/23 |
30/11/23 |
ASX - By Stock
|
94
|
22K
|
1
|
|
ASX - By Stock
|
MSB |
Re:
Share price today
|
|
RnessGness
|
94 |
22K |
3 |
30/11/23 |
30/11/23 |
ASX - By Stock
|
94
|
22K
|
3
|
|
ASX - By Stock
|
MSB |
Re:
Share price today
|
|
RnessGness
|
94 |
22K |
5 |
30/11/23 |
30/11/23 |
ASX - By Stock
|
94
|
22K
|
5
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast Partners with BMT CTN on Adult SR-aGVHD Trial
|
|
RnessGness
|
362 |
116K |
3 |
23/11/23 |
23/11/23 |
ASX - By Stock
|
362
|
116K
|
3
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Annual Report to Shareholders
|
|
RnessGness
|
74 |
24K |
17 |
30/10/23 |
30/10/23 |
ASX - By Stock
|
74
|
24K
|
17
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast Type A Meeting with FDA
|
|
RnessGness
|
574 |
191K |
6 |
28/09/23 |
28/09/23 |
ASX - By Stock
|
574
|
191K
|
6
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Trading Halt
|
|
RnessGness
|
1.3K |
543K |
3 |
09/08/23 |
09/08/23 |
ASX - By Stock
|
1.3K
|
543K
|
3
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Update on BLA for Graft Versus Host Disease
|
|
RnessGness
|
1.0K |
388K |
5 |
07/08/23 |
07/08/23 |
ASX - By Stock
|
1.0K
|
388K
|
5
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Update on BLA for Graft Versus Host Disease
|
|
RnessGness
|
1.0K |
388K |
6 |
07/08/23 |
07/08/23 |
ASX - By Stock
|
1.0K
|
388K
|
6
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Update on BLA for Graft Versus Host Disease
|
|
RnessGness
|
1.0K |
388K |
1 |
07/08/23 |
07/08/23 |
ASX - By Stock
|
1.0K
|
388K
|
1
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Update on BLA for Graft Versus Host Disease
|
|
RnessGness
|
1.0K |
388K |
14 |
06/08/23 |
06/08/23 |
ASX - By Stock
|
1.0K
|
388K
|
14
|
|
ASX - By Stock
|
MSB |
Re:
ODAC August 2020 event materials
|
|
RnessGness
|
85 |
25K |
9 |
20/07/23 |
20/07/23 |
ASX - By Stock
|
85
|
25K
|
9
|
|
ASX - By Stock
|
MSB |
Re:
2023 The Final Countdown
|
|
RnessGness
|
3.4K |
1.1M |
15 |
15/07/23 |
15/07/23 |
ASX - By Stock
|
3.4K
|
1.1M
|
15
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
RnessGness
|
17K |
6.6M |
8 |
14/07/23 |
14/07/23 |
ASX - By Stock
|
17K
|
6.6M
|
8
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Accepts Mesoblast's BLA Resubmission for Remestemcel-L
|
|
RnessGness
|
1.0K |
382K |
2 |
30/03/23 |
30/03/23 |
ASX - By Stock
|
1.0K
|
382K
|
2
|
|
ASX - By Stock
|
MSB |
Re:
2023 The Final Countdown
|
|
RnessGness
|
3.4K |
1.1M |
10 |
29/03/23 |
29/03/23 |
ASX - By Stock
|
3.4K
|
1.1M
|
10
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
RnessGness
|
17K |
6.6M |
3 |
24/03/23 |
24/03/23 |
ASX - By Stock
|
17K
|
6.6M
|
3
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Schedules GvHD Pre-License Manufacturing Inspection
|
|
RnessGness
|
275 |
110K |
11 |
24/03/23 |
24/03/23 |
ASX - By Stock
|
275
|
110K
|
11
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast Completes Resubmission of BLA to FDA for SR-aGVHD
|
|
RnessGness
|
914 |
286K |
5 |
19/02/23 |
19/02/23 |
ASX - By Stock
|
914
|
286K
|
5
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
RnessGness
|
17K |
6.6M |
1 |
15/02/23 |
15/02/23 |
ASX - By Stock
|
17K
|
6.6M
|
1
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
RnessGness
|
17K |
6.6M |
8 |
24/12/22 |
24/12/22 |
ASX - By Stock
|
17K
|
6.6M
|
8
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB AGM - confidence restored
|
|
RnessGness
|
304 |
91K |
6 |
05/12/22 |
05/12/22 |
ASX - By Stock
|
304
|
91K
|
6
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB AGM - confidence restored
|
|
RnessGness
|
304 |
91K |
10 |
05/12/22 |
05/12/22 |
ASX - By Stock
|
304
|
91K
|
10
|
|
ASX - By Stock
|
MSB |
Re:
Growing doubt on COVID-19 Application
|
|
RnessGness
|
4.7K |
1.0M |
8 |
05/12/22 |
05/12/22 |
ASX - By Stock
|
4.7K
|
1.0M
|
8
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
RnessGness
|
17K |
6.6M |
9 |
26/11/22 |
26/11/22 |
ASX - By Stock
|
17K
|
6.6M
|
9
|
|
ASX - By Stock
|
MSB |
Re:
2022 ... Get your popcorn out!
|
|
RnessGness
|
778 |
279K |
13 |
10/11/22 |
10/11/22 |
ASX - By Stock
|
778
|
279K
|
13
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Voluntary Suspension
|
|
RnessGness
|
332 |
117K |
14 |
08/08/22 |
08/08/22 |
ASX - By Stock
|
332
|
117K
|
14
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Pause in Trading
|
|
RnessGness
|
135 |
52K |
3 |
07/08/22 |
07/08/22 |
ASX - By Stock
|
135
|
52K
|
3
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Pause in Trading
|
|
RnessGness
|
135 |
52K |
19 |
07/08/22 |
07/08/22 |
ASX - By Stock
|
135
|
52K
|
19
|
|
ASX - By Stock
|
MSB |
Re:
banter and General Discussion
|
|
RnessGness
|
9.4K |
2.7M |
0 |
01/07/22 |
01/07/22 |
ASX - By Stock
|
9.4K
|
2.7M
|
0
|
|
ASX - By Stock
|
MSB |
Re:
Chronic Lower Back Pain - the sleeping giant.
|
|
RnessGness
|
484 |
146K |
9 |
17/06/22 |
17/06/22 |
ASX - By Stock
|
484
|
146K
|
9
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast to Host KOL Event on Chronic Low Back Pain
|
|
RnessGness
|
132 |
39K |
11 |
15/06/22 |
15/06/22 |
ASX - By Stock
|
132
|
39K
|
11
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
RnessGness
|
17K |
6.6M |
4 |
24/05/22 |
24/05/22 |
ASX - By Stock
|
17K
|
6.6M
|
4
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Litigation Update
|
|
RnessGness
|
82 |
24K |
9 |
20/05/22 |
20/05/22 |
ASX - By Stock
|
82
|
24K
|
9
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
RnessGness
|
17K |
6.6M |
14 |
27/03/22 |
27/03/22 |
ASX - By Stock
|
17K
|
6.6M
|
14
|
|
ASX - By Stock
|
MSB |
Re:
CHF Accelerated Approval !
|
|
RnessGness
|
144 |
56K |
5 |
24/03/22 |
24/03/22 |
ASX - By Stock
|
144
|
56K
|
5
|
|
ASX - By Stock
|
MSB |
Re:
CHF Accelerated Approval !
|
|
RnessGness
|
144 |
56K |
1 |
24/03/22 |
24/03/22 |
ASX - By Stock
|
144
|
56K
|
1
|
|
ASX - By Stock
|
MSB |
Re:
CHF Accelerated Approval !
|
|
RnessGness
|
144 |
56K |
1 |
19/03/22 |
19/03/22 |
ASX - By Stock
|
144
|
56K
|
1
|
|
ASX - By Stock
|
MSB |
Re:
Short Squeeze
|
|
RnessGness
|
505 |
160K |
5 |
18/03/22 |
18/03/22 |
ASX - By Stock
|
505
|
160K
|
5
|
|